Effectiveness, safety, and patterns of use of camrelizumab in advanced esophageal cancer: an individual patient data pooled analysis of 987 patients from three prospective cohort studies
This study provides an overview of camrelizumab use in unselected AEC patients. The real-world effectiveness and safety of camrelizumab are generally consistent with those observed in pivotal trials.
Authors
- Fengzhuo Cheng (ORCID: https://orcid.org/0000-0003-1367-252X)
- Rongrong Zheng (ORCID: https://orcid.org/0009-0001-0052-5128)
- Jun Zhao (ORCID: https://orcid.org/0000-0001-8903-8205)
- Zishu Wang (ORCID: https://orcid.org/0000-0002-1625-2195)
- Zhen Yang (ORCID: https://orcid.org/0000-0001-9763-6766)
- Shuanghu Yuan (ORCID: https://orcid.org/0000-0002-8327-2524)
- Wenjie Deng (ORCID: https://orcid.org/0000-0002-5052-0659)
- Wang Chen (ORCID: https://orcid.org/0000-0002-9093-5947)
- Na Li (ORCID: https://orcid.org/0009-0001-8624-0114)
- Yusheng Wang (ORCID: https://orcid.org/0000-0001-9774-7837)
- Junsheng Wang (ORCID: https://orcid.org/0000-0002-3220-3852)
- Lin Shen (ORCID: https://orcid.org/0000-0003-1134-2922)
- Jiancheng Li (ORCID: https://orcid.org/0000-0003-2148-9872)
- Suyi Li (ORCID: https://orcid.org/0000-0003-0581-0638)
- Zhe Yang (ORCID: https://orcid.org/0000-0003-4082-6088)
- Yinghua Ji
- Yanqiao Zhang (ORCID: https://orcid.org/0000-0001-5203-3814)
- Zhihao Lu
- Guoping Sun
- Dong Qian
- Fengming Ran
- Lixin Wan
- S. H. Zhu (ORCID: https://orcid.org/0000-0002-0633-3987)
Institutions
- Wannan Medical College (CN)
- Fujian Medical University (CN)
- Shandong University (CN)
- Harbin Medical University (CN)
- Shanxi Medical University (CN)
- Anhui Medical University (CN)
- Changzhi Medical College (CN)
- Peking University (CN)
- Peking University Cancer Hospital (CN)
- Ganzhou People's Hospital (CN)
- Suizhou Central Hospital (CN)
- Shandong Tumor Hospital (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
- First Affiliated Hospital of Xinxiang Medical University (CN)
- Nanyang Institute of Technology (CN)
- Shandong Provincial Hospital (CN)
- First Hospital of Shanxi Medical University (CN)
- Anhui Provincial Hospital (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Jiangsu Hengrui Medicine (China) (CN)
- Fujian Provincial Cancer Hospital (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
- First Affiliated Hospital of Bengbu Medical College (CN)
- Hubei Cancer Hospital (CN)
- Anyang Tumor Hospital (CN)
- Shandong First Medical University (CN)
- First Affiliated Hospital of Wannan Medical College (CN)
- Huazhong University of Science and Technology (CN)
- Henan Medical University (CN)
Publication Details
- Journal
- Cancer Immunology Immunotherapy
- Published
- 2025-03-08
- DOI
- https://doi.org/10.1007/s00262-025-03970-z
- Citations
- 4
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 8.03
Funders
- Jiangsu Hengrui Medicine